In patients suffering from dehydration and renal diseases, particularly the elderly. Concurrent therapy with other plasma protein binding drugs may decessitate a medication in dosage. In the case of anticoagulants, the dose of anticoagulant may need to be reduced. The safety of Mefenamic Acid in pregnancy and in children under 14 years of age has not been established.
Sign Out
